FDA Device Intelligence
HomeNURAMI MEDICAL LTD › ArtiFascia®

ArtiFascia®

NURAMI MEDICAL LTD · Model 3cm X 4cm (1.18" X 1.57") · UDI-DI 07290019685005

GXQ Prescription
1
510(k) clearances
1,404
Adverse events (36 deaths)
23
Recalls
42
Facilities

Description

ArtiFascia® is an absorbable dural repair graft for the repair of cranial dural defects. ArtiFascia® is a highly flexible, easy to handle, non-friable soft matrix composed of synthetic non-woven fibers and a non-porous film. ArtiFascia® readily conforms to the surface of the wound area and is applied to the dural defect by using sutures.

Recalls

DateFirmReason
2024-11-22Cook Biotech, Inc.Incorrect version of IFU was used rather than updated version; and incorrect expiration date was used on two of the products.
2024-09-26Integra LifeSciences Corp.Out of specification endotoxin levels.
2023-06-13Medtronic NeurosurgeryDura regeneration matrix may have out-of-specification endotoxin levels due to issues with in-process and finished goods endotoxin testing, which may present clinically with signs
2021-12-13Collagen Matrix, Inc.Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
2021-12-13Collagen Matrix, Inc.Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon
2015-12-08Synthes (USA) Products LLCIt was reported that the SYNTHECEL Dura Repair could adhere to various anatomical structures post implantation, which may expose patients to potential risks in the event a surgeon

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.